PD-L1 and Other Immuno-markers Influenced by Osimertinib Treatment in Advanced NSCLC Patients
Clinical trial NCT03029858 · UNKNOWN
Trial details
- NCT number
- NCT03029858
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-01
- Primary completion
- 2020-09-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.